Literature DB >> 20518681

Fatal respiratory events caused by zanamivir nebulization.

Helen M Steel, Amanda F Peppercorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20518681     DOI： 10.1086/653450

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

2.  Characteristics and mortality of severe influenza cases treated with parenteral aqueous zanamivir, United Kingdom, October 2009 to January 2011.

Authors:  Paul Robert Cleary; Jonathan Crofts; Frances Parry-Ford; Meera Chand; Nick Phin
Journal:  Influenza Other Respir Viruses       Date:  2018-10-19       Impact factor: 4.380
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.